Lipscomb M S, Walsh P N
J Clin Invest. 1979 May;63(5):1006-14. doi: 10.1172/JCI109368.
Because human platelets participate in the contact phase of intrinsic coagulation and contain a Factor XI-like coagulant activity, the nature of the Factor XI-like activity was examined and compared with purified plasma Factor XI. The platelet factor XI-like activity was sedimented with the particulate fraction of a platelet lysate, was inactivated by heat (t(1/2) 3.5 min, 56 degrees C), was not a nonspecific phospholipid activity, and was destroyed by treatment with Triton X-100. Isolated platelet membranes were four-fold enriched in Factor XI activity and similarly enriched in plasma membrane marker enzymes. The Factor XI-like activity of platelet membranes was detected only when assayed in the presence of kaolin, which suggests that it is present in an unactivated form and can participate in contact activation. Concanavalin A inhibited the Factor XI-like activity of platelet lysates and platelet membranes but not of plasma or purified Factor XI. A platelet membrane-Factor XI complex was isolated after incubation of membranes with purified Factor XI. The Factor XI activity of the platelet membrane-plasma Factor XI complex was inhibited by concanavalin A, whereas unbound plasma Factor XI retained activity. An antibody raised against plasma Factor XI inhibited the in vitro Factor XI activity of plasma and of the platelet membrane-plasma Factor XI complex but had no effect on the endogenous Factor XI-like activity of washed lysed platelets or isolated platelet membranes. Washed platelets and isolated platelet membranes obtained from a Factor XI-deficient donor without a history of excessive bleeding had normal quantities of platelet Factor XI-like activity and normal behavior in the contact phase of coagulation (collagen-induced coagulant activity). These results indicate that platelet membranes contain an endogenous Factor XI-like activity that is functionally distinct from plasma Factor XI.
由于人类血小板参与内源性凝血的接触阶段并含有一种类似因子XI的凝血活性,因此对这种类似因子XI的活性的性质进行了研究,并与纯化的血浆因子XI进行了比较。血小板中类似因子XI的活性与血小板裂解物的颗粒部分一起沉淀,可被热灭活(半衰期3.5分钟,56℃),不是非特异性磷脂活性,并且经Triton X-100处理后被破坏。分离的血小板膜中因子XI活性富集了四倍,并且在质膜标记酶中也同样富集。仅在高岭土存在下进行测定时,才检测到血小板膜的类似因子XI的活性,这表明它以未活化形式存在并且可以参与接触激活。伴刀豆球蛋白A抑制血小板裂解物和血小板膜的类似因子XI的活性,但不抑制血浆或纯化的因子XI的活性。在用纯化的因子XI孵育膜后,分离出一种血小板膜-因子XI复合物。伴刀豆球蛋白A抑制血小板膜-血浆因子XI复合物的因子XI活性,而未结合的血浆因子XI保留活性。针对血浆因子XI产生的抗体抑制血浆以及血小板膜-血浆因子XI复合物的体外因子XI活性,但对洗涤过的裂解血小板或分离的血小板膜的内源性类似因子XI的活性没有影响。从没有过度出血病史的因子XI缺乏供体获得的洗涤血小板和分离的血小板膜具有正常量的血小板类似因子XI的活性,并且在凝血接触阶段(胶原诱导的凝血活性)具有正常行为。这些结果表明,血小板膜含有一种内源性类似因子XI的活性,其在功能上与血浆因子XI不同。